TAKEDA PHARMACEUTICALS AMERICA, INC.

Takeda Pharmaceuticals America Inc. specializes in the manufacturing and supply of complex pharmaceutical preparations for federal agencies, with deep expertise in producing branded biologics and specialty therapeutics under strict cGMP standards. Their core capabilities include the end-to-end production of injectables, oral tablets, and bulk active pharmaceutical ingredients for niche indications, including rare disease treatments and immunotherapies. The company demonstrates advanced competency in managing multi-product supply chains, ensuring consistent quality across high-compliance environments, and maintaining secure, traceable distribution channels for controlled medications. Their technical focus centers on sterile manufacturing, lyophilization, and cold-chain logistics for temperature-sensitive biologics, with proven ability to support urgent, high-volume government demand cycles. The contractor maintains sustained relationships with the Department of Veterans Affairs and the Department of Justice, primarily supplying specialty pharmaceuticals to federal healthcare and correctional pharmacy systems. For the VA, they deliver critical therapies for hematologic, metabolic, and rare immune disorders, often through long-term blanket purchase agreements that ensure uninterrupted access to life-sustaining medications. The Department of Justice contracts reflect consistent provision of medications for federal detention and correctional facilities, indicating reliable compliance with federal formulary and controlled substance regulations. Their primary NAICS classification, 325412, reflects active pharmaceutical manufacturing of finished dosage forms, positioning them as a key supplier in the federal specialty drug market. They focus on high-complexity, low-volume therapeutics that require stringent regulatory oversight, distinguishing them from general pharmaceutical distributors. Takeda Pharmaceuticals America Inc. is a corporate entity headquartered in Lexington, Massachusetts, operating as a wholly owned subsidiary within a global pharmaceutical structure. The company holds no specific government certifications but leverages its FDA-registered manufacturing facilities and established quality systems to meet federal procurement requirements. Their geographic presence is centered in the Northeast biopharma corridor, with operations calibrated to support national government supply chain needs.